4SC
4SC discovers and develops targeted, small-molecule drugs for the treatment of cancer and autoimmune diseases in indications with high unmet medical needs. These drugs are intended to provide innovative treatment options that are more tolerable and efficacious, and provide a better quality of life.
4SC
Industry:
Biopharma Biotechnology Therapeutics
Founded:
1997-01-01
Address:
Planegg, Bayern, Germany
Country:
Germany
Website Url:
http://www.4sc.de
Total Employee:
51+
Status:
Active
Contact:
+490897007630
Email Addresses:
[email protected]
Total Funding:
94.7 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon WordPress Apache Wordpress Plugins Yoast WordPress SEO Plugin Yoast SEO Premium Yoast Plugins
Similar Organizations
Bright Peak Therapeutics
Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Chiasma
Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.
Cue Biopharma
Cue Biopharma has developed a highly productive platform for the treatment of cancer and autoimmune disease.
Nurix Therapeutics
Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.
Current Employees Featured
Stock Details
Investors List
Santo Holding
Santo Holding investment in Post-IPO Equity - 4SC
Wellington Partners
Wellington Partners investment in Post-IPO Equity - 4SC
Deutsche Venture Capital
Deutsche Venture Capital investment in Series C - 4SC
Mulligan BioCapital
Mulligan BioCapital investment in Series C - 4SC
BionX™ Medical Technologies
BionX™ Medical Technologies investment in Series C - 4SC
3i Group
3i Group investment in Series C - 4SC
Beteiligungsgesellschaft Neue Länder
Beteiligungsgesellschaft Neue Länder investment in Series B - 4SC
BioM AG
BioM AG investment in Series B - 4SC
Deutsche Venture Capital
Deutsche Venture Capital investment in Series B - 4SC
Bayern Kapital
Bayern Kapital investment in Series B - 4SC
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2015-11-02 | Panoptes Pharma | 4SC investment in Seed Round - Panoptes Pharma | N/A |
| 2008-05-26 | Nexigen | 4SC investment in Funding Round - Nexigen | N/A |
Official Site Inspections
http://www.4sc.de Semrush global rank: 9.75 M Semrush visits lastest month: 113
- Host name: 46.30.63.120
- IP address: 46.30.63.120
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
